Suboxone.com - Opioid Dependence Screening Kit

The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "View PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

You are leaving Suboxone.com. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Clicking on "Continue" will take you to a website that is outside the control of Reckitt Benckiser Pharmaceuticals. You are solely responsible for your interactions with such websites.

Links are provided as a public service and for informational purposes only.

You are leaving Suboxone.com and are being redirected to HereToHelpProgram.com, the website that contains the information you requested. HereToHelpProgram.com and Suboxone.com are owned and operated by Reckitt Benckiser Pharmaceuticals Inc.

As always, your information will not be sold or shared with anyone. See our privacy policy for more information.

IMPORTANT INFORMATION:

On December 8, 2006, Federal legislation was passed allowing physicians to treat up to 100 opioid-dependent patients with Suboxone at any given time—a significant increase from the previous limit of 30 patients.

There may be doctors in your area participating in a study to measure opioid dependence treatment outcomes. Patients who meet the eligibility requirements to participate in this study can receive up to $225 in compensation to complete surveys about their treatment.

NOTE: This study is only open to patients not currently under the care of a physician for opioid dependence and are seeking a treatment provider.

Please call 1-866-455-8876 between 9:00 AM to 7:30 PM EST to get more information.

Seeking Information for myself or loved one

Here to Help™ provides support throughout treatment. Whether you're seeking treatment information or you're already in treatment, we can provide resources that can help you make treatment a success.

HereToHelpProgram.com respects your privacy.
Read our Privacy Policy for more information.

If you can read this, then your browser cannot interpret Javascript. To take full advantage of what this website has to offer, please make sure that you have Javascript enabled in your browser preferences, or update to a browser that supports Javascript. Thank you.

Prescribing Information -- Site Map

Support That Helps Patients Stay In Treatment

Learn how patients can benefit from this free support system

Become a Here to Help Provider

Learn how becoming a provider can benefit you and your practice

Opioid Dependence Screening Kit

For Healthcare Professional Use Only

If you are not a Healthcare Professional and you need assistance or would like additional information, please contact the Suboxone Help Line at 877-782-6966 or 877-SUBOXONE or access the physician locator.

The Opioid Dependence Screening Kit will help you identify opioid-dependent patients and make a difference in their lives today.

You can order your free Opioid Dependence Screening Kit by providing your mailing information below. If you wish, you also may sign up to receive future information from Reckitt Benckiser Pharmaceuticals Inc. about treating opioid dependence with SUBOXONE (buprenorphine/naloxone). SUBOXONE is a prescription medicine that is used in a doctor's office to treat opioid dependence.

Please check here if you would like to receive future educational information and materials on opioid dependence and its treatment from Reckitt Benckiser Pharmaceuticals Inc.. Please let us know how to reach you:

E-mail Address

If at any time in the future you would like to stop receiving educational materials from Reckitt Benckiser Pharmaceuticals Inc., please call 1-866-455-TURN or e-mail suboxone.unsubscribe@dsuccess.com.

To order your free Opioid Dependence Screening Kit on opioid dependence and its treatment, please fill out the information below.

*Items with an asterisk are required.

We want you to know how we will use your information. Your information will only be used by Reckitt Benckiser Pharmaceuticals Inc. for purposes relating to the Company's programs, products, and services and not for any other purpose.

We invite you to review the Reckitt Benckiser Privacy Policy by clicking here.

First Name*
Last Name*
Address*
City*
State*
Zip Code*

Where did you hear about the Opioid Dependence Screening Kit?

Please check one*

For Healthcare Professional Use Only

Home -- About SUBOXONE -- Here to Help -- Treatment -- Certification -- Pharmacists -- Counselors -- Nurses -- Resources

SUBOXONE^®, SUBUTEX^®, and Here to Help^® are registered trademarks of Reckitt Benckiser Healthcare (UK) Ltd.

Important Safety Information

SUBOXONE^® (buprenorphine HCl/naloxone HCl dihydrate sublingual tablets) (CIII) is indicated for the treatment of opioid dependence.

It is extremely dangerous to self-administer non-prescribed benzodiazepines or other depressants while taking SUBOXONE. A serious overdose and death may occur if benzodiazepines, sedatives, tranquilizers, antidepressants, or alcohol are taken at the same time as SUBOXONE.

SUBOXONE has potential for abuse and produces dependence of the opioid type, with a milder withdrawal syndrome than full agonists.

Cytolytic hepatitis and hepatitis with jaundice have been observed in the addicted population receiving buprenorphine.

Allergic reactions including bronchospasm, angioneurotic edema, and anaphylactic shock have been reported in patients taking buprenorphine.

There are no adequate and well-controlled studies of SUBOXONE (a Category C medication) in pregnancy.

Caution should be exercised when driving cars or operating machinery.

Always store buprenorphine-containing medications safely and out of the reach and sight of children. Destroy any unused medication appropriately.

The most commonly reported adverse events with SUBOXONE include: headache (36%, placebo 22%), withdrawal syndrome (25%, placebo 37%), pain (22%, placebo 19%), insomnia (14%, placebo 16%), nausea (15%, placebo 11%), and sweating (14%, placebo 10%). Please see full Prescribing Information for a complete list.

To report an adverse event caused by taking SUBOXONE, please call 1-877-782-6966. You are also encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information